Quantitative determination of pravastatin and its biotransformation products in human serum by turbo ion spray LC/MS/MS
- 14 September 2000
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 23 (5) , 851-866
- https://doi.org/10.1016/s0731-7085(00)00372-1
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The use of high-flow high performance liquid chromatography coupled with positive and negative ion electrospray tandem mass spectrometry for quantitative bioanalysis via direct injection of the plasma/serum samplesRapid Communications in Mass Spectrometry, 1998
- An automated method for the simultaneous determination of pravastatin and its main metabolite in human plasma by high-performance liquid chromatography/atmospheric pressure chemical ionization mass spectrometryBiomedical Chromatography, 1998
- Determination of pravastatin in human plasma by high-performance liquid chromatography with ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- PravastatinDrugs, 1997
- Enzyme-Linked Immunosorbent Assay of Pravastatin, a MG-CoA Reductase Inhibitor, in Human PlasmaJournal of Immunoassay, 1996
- Clinical Pharmacokinetics of PravastatinClinical Pharmacokinetics, 1994
- High-Performance Liquid Chromatography Determination of Pravastatin in PlasmaTherapeutic Drug Monitoring, 1994
- Determination of the HMG-CoA reductase inhibitors simvastatin, lovastatin, and pravastatin in plasma by gas chromatography/chemical ionization mass spectrometryJournal of Mass Spectrometry, 1993
- PravastatinDrugs, 1991
- Determination of pravastatin sodium and its major metabolites in human serum/plasma by capillary gas chromatography/negative ion chemical ionization mass spectrometryJournal of Mass Spectrometry, 1989